MUMBAI — Procter & Gamble Health Limited has formalized the re-appointment of senior financial executive Subramanian Madhavan as an Independent Director on its Board of Directors.
The renewed five-year term takes effect on November 15, 2026, and runs through November 14, 2031, subject to final shareholder ratification. The decision aligns with SEBI listing regulations and statutory corporate governance frameworks.
